Amarin, FDA Off-Label Promotion Suit Stayed Until Feb.
A New York federal judge on Thursday halted a suit between Amarin Pharma Inc. and the U.S. Food and Drug Administration — in which the court had previously ruled Amarin can...To view the full article, register now.
Already a subscriber? Click here to view full article